EX-99.1 2 drr0466_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507

Tel : +91 40 4900 2900

Fax : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

February 28, 2023

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

Dear Sirs,

Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform you that the Company’s management will be participating in the following investor conferences / group investor meetings:

Date	Meeting	Location
28^th Feb’ 2023	BofA Healthcare Tour	Hyderabad
28^th Feb’ 2023	Ambit India Access - Healthcare Tour	Hyderabad
2^nd Mar’ 2023	Goldman Sachs India Pharma and Healthcare Tour	Hyderabad
2^nd Mar’ 2023	Investor Group meeting	Singapore

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

/s/ K Randhir Singh
K Randhir Singh

Company Secretary, Compliance Officer and Head CSR

CC:- New York Stock Exchange Inc.(Stock Code :RDY)

NSE IFSC Ltd